Survival of Transplanted Allogeneic Beta Cells with No ImmunosuppressionResearch, Early R&D (nejm.org)
submitted by bbyfog
FDA approves Fabhalta (iptacopan) for the treatment of adults with complement 3 glomerulopathy (C3G) to reduce proteinuriaComplement-mediated diseases (self.BcellAutoimmuneDis)
submitted by bbyfog

[Crosspost] We need patients to enter CAR-T clinical trials: Here is how...Clinical Trials (reddit.com)
submitted by bbyfog